The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Abstract
Sexually transmitted diseases (STDs) constitute an epidemic of tremendous magnitude, with an estimated 18.9 million persons acquiring a new STD each year [1]. Reported disease rates underestimate the true burden of infection because the majority of STDs are asymptomatic and because of underreporting. STDs have far-reaching public health consequences for the sexual and reproductive health of individual persons, as well as for the long-term health and health care costs of the community. The accurate identification and the effective clinical management of STDs represent an important combined strategy necessary to improve reproductive and sexual health and to improve HIV prevention efforts. This is especially relevant to women, adolescents, and infants, because untreated infections frequently result in severe, long-term complications, including facilitation of HIV infection, tubal infertility, adverse pregnancy outcomes, and cancer. For >20 years, the publication of national guidelines by the Centers for Disease Control and Prevention (CDC) for the management of STDs has assisted clinicians with effective guidance on the delivery of optimal STD care. The CDC STD treatment guidelines are the most widely referenced and authoritative source of information on STD treatment and prevention strategies for clinicians who evaluate persons with STDs or those at risk for STDs. The 2006 CDC guidelines for the treatment of sexually transmitted diseases were developed in consultation with public- and private-sector professionals knowledgeable in the management of STDs [2]. An evidence-based systematic review was performed, focusing on peer-reviewed journal articles and abstracts that had become available since publication of the 2002 CDC STD treatment guidelines. Evidence tables were developed from systematic reviews that summarized the study type, population and setting, treatment regimens or other interventions, outcome measures, and potential limitations of the reported findings. This supplement to Clinical Infectious Diseases contains 9 background articles that describe the available evidence in several topic areas included in the 2006 CDC STD treatment guidelines. Current advances and controversies are described in the diagnosis, management, and treatment of various sexually transmitted pathogens and syndromes that have important implications for clinical practice. Chlamydia trachomatis infection is the most common bacterial STD in the United States, with an estimated 3 million cases occurring annually [3]. Reported rates of chlamydial infection have increased dramatically over the past decade, reflecting expansion of chlamydial screening activities, highly sensitive nucleic acid amplification tests, and improvements in information systems used for reporting. However, many women who are at risk for this infection are still not being screened appropriately, reflecting, in part, a lack of awareness among some providers, as well as limited resources. Health care providers frequently rely on screening tests, because asymptomatic infection is common among both men and women. Annual screening of all sexually active women ⩽25 years of age is recommended [4], as is screening of older women with risk factors (e.g., those who have a new sex partner or multiple sex partners). There is insufficient evidence to recommend routine screening for C. trachomatis in sexually active young men on the basis of feasibility, efficacy, and cost-effectiveness; however, screening should be considered in high-prevalence areas, such as adolescent clinics, correctional facilities, and STD clinics. Efficacious therapeutic regimens for chlamydia include azithromycin or doxycycline. Because of the high probability of repeat infection, women should be retested for chlamydial infection 3–4 months after treatment [5]. Clinical experience and limited studies are available to support the efficacy and safety of azithromycin as a recommended regimen in pregnant women. Infections with Neisseria gonorrhoeae account for the second most commonly notifiable disease in the United States [3] and are an important cause of cervicitis, urethritis, proctitis, and pelvic inflammatory disease. Selection of appropriate therapy for gonorrhea is guided by a CDC-sponsored surveillance system (Gonococcal Isolate Surveillance Project) that has monitored gonococcal antimicrobial susceptibility for the past 20 years. Of recent concern, the prevalence of quinolone-resistant N. gonorrhoeae has increased in many areas of the United States and among men who have sex with men, resulting in changes in recommended treatment regimens. The CDC Web site [6] or state and local health departments can provide the most current information on quinolone-resistant N. gonorrhoeae prevalence. Because prevalence can vary greatly by location, state and local public health officials should maintain the capacity to detect and monitor the prevalence of resistant strains. Oral alternatives to quinolones
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fleming, D. T., & Wasserheit, J. N. (1999) · Sexually Transmitted Infections · doi:10.1136/sti.75.1.3 · Cited by 2,271
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
Kreimer, A. R., Clifford, G. M., Boyle, P., & Franceschi, S. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0551 · Cited by 2,184
Sexually transmitted diseases treatment guidelines
Burstein, G. R., & Workowski, K. A. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200308000-00006 · Cited by 2,072
Self-citationMarkowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007) · PsycEXTRA Dataset · doi:10.1037/e601292007-001 · Cited by 1,882
Sexually transmitted disease surveillance.
Schofield, C. B. (1982) · BMJ · doi:10.1136/bmj.284.6318.825-c · Cited by 1,869
Le, M. (2007) · Medical Entomology and Zoology · Cited by 1,624
Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000
Weinstock, H., Berman, S., & Cates, W. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3600604 · Cited by 1,258
Self-citationSexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000
Weinstock, H., Berman, S., & Cates, W. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1111/j.1931-2393.2004.tb00002.x · Cited by 1,153
Self-citationMast, E. E., Weinbaum, C. M., Fiore, A. E., Alter, M. J., Bell, B. P., Finelli, L., Rodewald, L. E., Douglas, J. M., Janssen, R. S., & Ward, J. W. (2006) · PubMed · Cited by 1,132
1993 Sexually Transmitted Diseases Treatment Guidelines
(1994) · Journal of School Health · doi:10.1111/j.1746-1561.1994.tb03287.x · Cited by 918
Cited by
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., Halperin, J. J., Steere, A. C., Klempner, M. S., Krause, P. J., Bakken, J. S., Strle, F., Stanek, G., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/508667 · Cited by 2,087
Newman, L., Rowley, J., Vander Hoorn, S., Wijesooriya, N. S., Unemo, M., Low, N., Stevens, G., Gottlieb, S., Kiarie, J., & Temmerman, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143304 · Cited by 1,603
Patel, P., Hanson, D. L., Sullivan, P. S., Novak, R. M., Moorman, A. C., Tong, T. C., Holmberg, S. D., Brooks, J. T., & for the Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00005 · Cited by 942
Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01463-09 · Cited by 914
Bradshaw, C. S., Morton, A. N., Hocking, J., Garland, S. M., Morris, M. B., Moss, L. M., Horvath, L. B., Kuzevska, I., & Fairley, C. K. (2006) · The Journal of Infectious Diseases · doi:10.1086/503780 · Cited by 790
Bacterial vaginosis and HIV acquisition: A meta-analysis of published studies
Atashili, J., Poole, C., Ndumbe, P. M., Adimora, A. A., & Smith, J. S. (2008) · AIDS · doi:10.1097/qad.0b013e3283021a37 · Cited by 706
Peeling, R. W., Mabey, D., Kamb, M. L., Chen, X.-S., Radolf, J. D., & Benzaken, A. S. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.73 · Cited by 664
Risk of Sequelae after Chlamydia trachomatis Genital Infection in Women
Haggerty, C. L., Gottlieb, S. L., Taylor, B. D., Low, N., Xu, F., & Ness, R. B. (2010) · The Journal of Infectious Diseases · doi:10.1086/652395 · Cited by 657
Günthard, H. F., Saag, M. S., Benson, C. A., del Rio, C., Eron, J. J., Gallant, J. E., Hoy, J. F., Mugavero, M. J., Sax, P. E., Thompson, M. A., et al. (2016) · JAMA · doi:10.1001/jama.2016.8900 · Cited by 656
LaFond, R. E., & Lukehart, S. A. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.29-49.2006 · Cited by 634
Wi, T., Lahra, M. M., Ndowa, F., Bala, M., Dillon, J.-A. R., Ramon-Pardo, P., Eremin, S. R., Bolan, G., & Unemo, M. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002344 · Cited by 600
Conjunctivitis: A Systematic Review of Diagnosis and Treatment
Azari, A. A., & Barney, N. P. (2013) · JAMA · doi:10.1001/jama.2013.280318 · Cited by 597
Fatahzadeh, M., & Schwartz, R. A. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.06.027 · Cited by 570
Saslow, D., Castle, P. E., Cox, J. T., Davey, D. D., Einstein, M. H., Ferris, D. G., Goldie, S. J., Harper, D. M., Kinney, W., Moscicki, A.-B., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.7 · Cited by 521
Sutton, M., Sternberg, M., Koumans, E. H., McQuillan, G., Berman, S., & Markowitz, L. (2007) · Clinical Infectious Diseases · doi:10.1086/522532 · Cited by 490
Self-citation2012 European guideline on the diagnosis and treatment of gonorrhoea in adults
Bignell, C., Unemo, M., The European STI Guidelines Editorial Board, Radcliffe, K., Jensen, J. S., Babayan, K., Barton, S., Cusini, M., Gomberg, M., Janier, M., et al. (2013) · International Journal of STD & AIDS · doi:10.1177/0956462412472837 · Cited by 483
Kucharzik, T., Ellul, P., Greuter, T., Rahier, J. F., Verstockt, B., Abreu, C., Albuquerque, A., Allocca, M., Esteve, M., Farraye, F. A., et al. (2021) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjab052 · Cited by 480
Molina, J.-M., Charreau, I., Chidiac, C., Pialoux, G., Cua, E., Delaugerre, C., Capitant, C., Rojas-Castro, D., Fonsart, J., Bercot, B., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30725-9 · Cited by 449
Celum, C., Wald, A., Hughes, J., Sanchez, J., Reid, S., Delany-Moretlwe, S., Cowan, F., Casapia, M., Ortiz, A., Fuchs, J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60920-4 · Cited by 449
Systematic review of the incidence and prevalence of genital warts
Patel, H., Wagner, M., Singhal, P., & Kothari, S. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-39 · Cited by 428
A smartphone dongle for diagnosis of infectious diseases at the point of care
Laksanasopin, T., Guo, T. W., Nayak, S., Sridhara, A. A., Xie, S., Olowookere, O. O., Cadinu, P., Meng, F., Chee, N. H., Kim, J., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa0056 · Cited by 425
2020 European guideline on the management of syphilis
Janier, M., Unemo, M., Dupin, N., Tiplica, G. S., Potočnik, M., & Patel, R. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16946 · Cited by 421
Sonnenberg, P., Clifton, S., Beddows, S., Field, N., Soldan, K., Tanton, C., Mercer, C. H., da Silva, F. C., Alexander, S., Copas, A. J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61947-9 · Cited by 370
2014 European guideline on the management of syphilis
Janier, M., Hegyi, V., Dupin, N., Unemo, M., Tiplica, G. S., Potočnik, M., French, P., & Patel, R. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12734 · Cited by 360
Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use
Dalhoff, A. (2012) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2012/976273 · Cited by 354
Ravel, J., Brotman, R. M., Gajer, P., Ma, B., Nandy, M., Fadrosh, D. W., Sakamoto, J., Koenig, S. S., Fu, L., Zhou, X., et al. (2013) · Microbiome · doi:10.1186/2049-2618-1-29 · Cited by 353
Swidsinski, A., Mendling, W., Loening-Baucke, V., Swidsinski, S., Dörffel, Y., Scholze, J., Lochs, H., & Verstraelen, H. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.06.039 · Cited by 335
Cicinelli, E., Matteo, M., Tinelli, R., Pinto, V., Marinaccio, M., Indraccolo, U., De Ziegler, D., & Resta, L. (2014) · Reproductive Sciences · doi:10.1177/1933719113508817 · Cited by 333
2015 European guideline on the management of Chlamydia trachomatis infections
Lanjouw, E., Ouburg, S., de Vries, H., Stary, A., Radcliffe, K., & Unemo, M. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462415618837 · Cited by 328
Repeat Infection With Chlamydia and Gonorrhea Among Females: A Systematic Review of the Literature
Hosenfeld, C. B., Workowski, K. A., Berman, S., Zaidi, A., Dyson, J., Mosure, D., Bolan, G., & Bauer, H. M. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181a2a933 · Cited by 326
Self-citationScreening for Chlamydia and Gonorrhea: U.S. Preventive Services Task Force Recommendation Statement
LeFevre, M. L., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m14-1981 · Cited by 304
Treatment of Syphilis: A Systematic Review
Clement, M. E., Okeke, N. L., & Hicks, C. B. (2014) · JAMA · doi:10.1001/jama.2014.13259 · Cited by 298
IUSTI: 2008 European Guidelines on the Management of Syphilis
French, P., Gomberg, M., Janier, M., Schmidt, B., van Voorst Vader, P., & Young, H. (2009) · International Journal of STD & AIDS · doi:10.1258/ijsa.2008.008510 · Cited by 294
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective
Brotman, R. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57172 · Cited by 283
Sexual sequelae of general medical disorders
Basson, R., & Weijmar Schultz, W. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60197-4 · Cited by 283
Emergence of Global Antibiotic Resistance
Morehead, M. S., & Scarbrough, C. (2018) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2018.05.006 · Cited by 280
Kalia, N., Singh, J., & Kaur, M. (2020) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-020-0347-4 · Cited by 275
UK national guideline for the management of gonorrhoea in adults, 2011
Bignell, C., FitzGerald, M., & (Guideline Development Group) (2011) · International Journal of STD & AIDS · doi:10.1258/ijsa.2011.011267 · Cited by 270
History of Antibiotics. From Salvarsan to Cephalosporins
Zaffiri, L., Gardner, J., & Toledo-Pereyra, L. H. (2012) · Journal of Investigative Surgery · doi:10.3109/08941939.2012.664099 · Cited by 260
Syphilis: using modern approaches to understand an old disease
Ho, E. L., & Lukehart, S. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57173 · Cited by 256
Bacterial Keratitis Preferred Practice Pattern®
Lin, A., Rhee, M. K., Akpek, E. K., Amescua, G., Farid, M., Garcia-Ferrer, F. J., Varu, D. M., Musch, D. C., Dunn, S. P., & Mah, F. S. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2018.10.018 · Cited by 255
Isolation of vaginal lactobacilli and characterization of anti-candida activity
Parolin, C., Marangoni, A., Laghi, L., Foschi, C., Ñahui Palomino, R. A., Calonghi, N., Cevenini, R., & Vitali, B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131220 · Cited by 228
The evaluation of children in the primary care setting when sexual abuse is suspected.
Jenny, C., Crawford-Jakubiak, J. E., COMMITTEE ON CHILD ABUSE AND NEGLECT, Jenny, C., Crawford-Jakubiak, J. E., Christian, C. W., Crawford-Jakubiak, J. E., Flaherty, E. G., Leventhal, J. M., Lukefahr, J. L., et al. (2013) · PEDIATRICS · doi:10.1542/peds.2013-1741 · Cited by 222
Neurosyphilis in a clinical cohort of HIV-1-infected patients.
Ghanem, K. G., Moore, R. D., Rompalo, A. M., Erbelding, E. J., Zenilman, J. M., & Gebo, K. A. (2008) · AIDS · doi:10.1097/qad.0b013e32830184df · Cited by 212
Patton, M. E., Kidd, S., Llata, E., Stenger, M., Braxton, J., Asbel, L., Bernstein, K., Gratzer, B., Jespersen, M., Kerani, R., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu184 · Cited by 206
Warner, L., Stone, K. M., Macaluso, M., Buehler, J. W., & Austin, H. D. (2006) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000187908.42622.fd · Cited by 187
Pond, M. J., Nori, A. V., Witney, A. A., Lopeman, R. C., Butcher, P. D., & Sadiq, S. T. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit752 · Cited by 184
Ghanem, K. G., Erbelding, E. J., Wiener, Z. S., & Rompalo, A. M. (2007) · Sexually Transmitted Infections · doi:10.1136/sti.2006.021402 · Cited by 177
Solomon, M. M., Mayer, K. H., Glidden, D. V., Liu, A. Y., McMahan, V. M., Guanira, J. V., Chariyalertsak, S., Fernandez, T., Grant, R. M., Bekker, L.-G., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu450 · Cited by 159
Seña, A. C., Zhang, X.-H., Li, T., Zheng, H.-P., Yang, B., Yang, L.-G., Salazar, J. C., Cohen, M. S., Moody, M. A., Radolf, J. D., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1209-0 · Cited by 150
Azithromycin-resistant syphilis infection: San Francisco, California, 2000–2004.
Mitchell, S. J., Engelman, J., Kent, C. K., Lukehart, S. A., Godornes, C., & Klausner, J. D. (2006) · Clinical Infectious Diseases · doi:10.1086/498899 · Cited by 137
Sena, A. C., Wolff, M., Martin, D. H., Behets, F., Van Damme, K., Leone, P., Langley, C., McNeil, L., & Hook, E. W. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir671 · Cited by 132
Probiotics for vulvovaginal candidiasis in non-pregnant women
Xie, H. Y., Feng, D., Wei, D. M., Mei, L., Chen, H., Wang, X., & Fang, F. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010496.pub2 · Cited by 129
McNamee, K. M., Dawood, F., & Farquharson, R. G. (2014) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2013.10.007 · Cited by 125
Pathela, P., Braunstein, S. L., Schillinger, J. A., Shepard, C., Sweeney, M., & Blank, S. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318230e1ca · Cited by 124
Kirkcaldy, R. D., Zaidi, A., Hook, E. W., Holmes, K. K., Soge, O., del Rio, C., Hall, G., Papp, J., Bolan, G., & Weinstock, H. S. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00004 · Cited by 115
Park, I. U., Chow, J. M., Bolan, G., Stanley, M., Shieh, J., & Schapiro, J. M. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir524 · Cited by 103
Zhu, Y.-X., Li, T., Fan, S.-R., Liu, X.-P., Liang, Y.-H., & Liu, P. (2016) · Health and Quality of Life Outcomes · doi:10.1186/s12955-016-0470-2 · Cited by 88
Martin, I. E., Gu, W., Yang, Y., & Tsang, R. S. W. (2009) · Clinical Infectious Diseases · doi:10.1086/600878 · Cited by 85
Barbee, L. A., Dhanireddy, S., Tat, S. A., & Marrazzo, J. M. (2015) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000320 · Cited by 85
Confronting Rising STIs in the Era of PrEP and Treatment as Prevention
Ramchandani, M. S., & Golden, M. R. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00446-5 · Cited by 84
Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods
Satora, M., Grunwald, A., Zaremba, B., Frankowska, K., Żak, K., Tarkowski, R., & Kułak, K. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165376 · Cited by 84
Epidemiology, Natural History, Diagnosis, and Treatment of Trichomonas vaginalis in Men
Van Gerwen, O. T., Camino, A. F., Sharma, J., Kissinger, P. J., & Muzny, C. A. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab514 · Cited by 81
Wong, T., Singh, A. E., & De, P. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.04.042 · Cited by 79
Screen more or screen more often? Using mathematical models to inform syphilis control strategies.
Tuite, A. R., Fisman, D. N., & Mishra, S. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-606 · Cited by 70
Sena, A. C., Wolff, M., Behets, F., Van Damme, K., Martin, D. H., Leone, P., McNeil, L., & Hook, E. W. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis918 · Cited by 69
Joseph, R. J., Ser, H.-L., Kuai, Y.-H., Tan, L. T.-H., Arasoo, V. J. T., Letchumanan, V., Wang, L., Pusparajah, P., Goh, B.-H., Ab Mutalib, N.-S., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10060719 · Cited by 68
Adachi, K. N., Nielsen-Saines, K., & Klausner, J. D. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.531073 · Cited by 66
A Randomized Phase 2 Study of VT-1161 for the Treatment of Acute Vulvovaginal Candidiasis
Brand, S. R., Sobel, J. D., Nyirjesy, P., Ghannoum, M. A., Schotzinger, R. J., & Degenhardt, T. P. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1204 · Cited by 61
US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Donahue, K., Doubeni, C. A., Epling, J. W., et al. (2020) · JAMA · doi:10.1001/jama.2020.13095 · Cited by 59
Collins, L. M., Moore, R., & Sobel, J. D. (2020) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000496 · Cited by 55
Ganesan, A., Mesner, O., Okulicz, J. F., O'Bryan, T., Deiss, R. G., Lalani, T., Whitman, T. J., Weintrob, A. C., Macalino, G., & Agan, B. K. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu888 · Cited by 54
Cao, Y., Su, X., Wang, Q., Xue, H., Zhu, X., Zhang, C., Jiang, J., Qi, S., Gong, X., Zhu, X., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix611 · Cited by 51
Olaleye, A. O., Babah, O. A., Osuagwu, C. S., Ogunsola, F. T., & Afolabi, B. B. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.10.002 · Cited by 47
Prevalence and predictors of sexually transmitted infection among newly incarcerated females.
Willers, D. M., Peipert, J. F., Allsworth, J. E., Stein, M. D., Rose, J. S., & Clarke, J. G. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318154bdb2 · Cited by 49
Factors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis
Sobel, J. (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s38984 · Cited by 48
Oral Ibrexafungerp: An Investigational Agent for the Treatment of Vulvovaginal Candidiasis
Azie, N., Angulo, D., Dehn, B., & Sobel, J. D. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1791820 · Cited by 46
Bacterial vaginosis: A state of microbial dysbiosis
Mondal, A. S., Sharma, R., & Trivedi, N. (2023) · Medicine in Microecology · doi:10.1016/j.medmic.2023.100082 · Cited by 44
Meta-analysis of ceftriaxone compared with penicillin for the treatment of syphilis
Liang, Z., Chen, Y.-P., Yang, C.-S., Guo, W., Jiang, X.-X., Xu, X.-F., Feng, S.-X., Liu, Y.-Q., & Jiang, G. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.10.020 · Cited by 44
Du Mont, J., Myhr, T. L., Husson, H., Macdonald, S., Rachlis, A., & Loutfy, M. R. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181824f3c · Cited by 41
Qin, J.-B., Feng, T.-J., Yang, T.-B., Hong, F.-C., Lan, L.-N., Zhang, C.-L., Liu, X.-L., Yang, Y.-Z., Xiao, S.-Y., & Tan, H.-Z. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2186-8 · Cited by 39
Muzny, C. A., Austin, E. L., Harbison, H. S., & Hook, E. W. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000194 · Cited by 37
De Cremer, K., De Brucker, K., Staes, I., Peeters, A., Van den Driessche, F., Coenye, T., Cammue, B. P. A., & Thevissen, K. (2016) · Scientific Reports · doi:10.1038/srep27463 · Cited by 34
Insights into the CRISPR/Cas system of Gardnerella vaginalis
Pleckaityte, M., Zilnyte, M., & Zvirbliene, A. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-301 · Cited by 33
Leeyaphan, C., Ong, J. J., Chow, E. P. F., Kong, F. Y. S., Hocking, J. S., Bissessor, M., Fairley, C. K., & Chen, M. (2016) · Emerging infectious diseases · doi:10.3201/eid2210.160986 · Cited by 31
Clinical Aspects of Syphilis Reinfection in HIV-Infected Patients
Courjon, J., Hubiche, T., Dupin, N., Grange, P. A., & Del Giudice, P. (2015) · Dermatology · doi:10.1159/000369617 · Cited by 31
Reed, J. L., Huppert, J. S., Gillespie, G. L., Taylor, R. G., Holland, C. K., Alessandrini, E. A., & Kahn, J. A. (2015) · Academic Emergency Medicine · doi:10.1111/acem.12557 · Cited by 29
Anderson, C., Gallo, M. F., Hylton-Kong, T., Steiner, M. J., Hobbs, M. M., Macaluso, M., Figueroa, J. P., Jamieson, D. J., Legardy-Williams, J., Wiener, J., et al. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31827938a1 · Cited by 27
Hiransuthikul, A., Janamnuaysook, R., Sungsing, T., Jantarapakde, J., Trachunthong, D., Mills, S., Vannakit, R., Phanuphak, P., & Phanuphak, N. (2019) · Sexually Transmitted Infections · doi:10.1136/sextrans-2018-053835 · Cited by 25
Gallion, H. R., Dupree, L. J., Scott, T. A., & Arnold, D. H. (2009) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2008.12.006 · Cited by 25
Cole, J., Hotton, A., Zawitz, C., & Kessler, H. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000106 · Cited by 21
Osbak, K. K., Tsoumanis, A., De Baetselier, I., Van Esbroek, M., Smet, H., Kenyon, C. R., & Crucitti, T. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035838 · Cited by 15
Risk of myocardial infarction in women with pelvic inflammatory disease
Liou, T.-H., Wu, C.-W., Hao, W.-R., Hsu, M.-I., Liu, J.-C., & Lin, H.-W. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.01.006 · Cited by 14
Data on Safety of Intravaginal Boric Acid Use in Pregnant and Nonpregnant Women: A Narrative Review
Mittelstaedt, R., Kretz, A., Levine, M., Handa, V. L., Ghanem, K. G., Sobel, J. D., Powell, A., & Tuddenham, S. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001562 · Cited by 14
Syphilis and a pregnant woman: a real danger for the woman and the child
Plagens-Rotman, K., Przybylska, R., Gerke, K., Piskorz-Szymendera, M., Tomaszewska, M., Sadowska-Przytocka, A., Adamski, Z., & Czarnecka-Operacz, M. (2019) · Advances in Dermatology and Allergology · doi:10.5114/ada.2019.82833 · Cited by 10
Nishiki, S., Arima, Y., Kanai, M., Shimuta, K., Nakayama, S.-I., & Ohnishi, M. (2020) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2020.05.022 · Cited by 8
(2022) · PubMed Central · doi:10.19852/j.cnki.jtcm.2022.04.001 · Cited by 4
Metadata
- Authors
- Workowski, K. A., & Berman, S. M.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-01
- Volume
- 44
- Issue
- Supplement 3
- Pages
- S73-S76
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2162847806
- Cited by
- 1,973
- References
- 54
- FWCI
- 101.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.